Highlights Aurobindo Pharma

Equities

AUROPHARMA

INE406A01037

Market Closed - NSE India S.E. Other stock markets 07:43:47 2024-05-10 am EDT			5-day change	1st Jan Change
1,128 ^INR	+1.10%		-2.09%	+4.02%

May. 08	India's Hindalco mulls seeking $1.2 bln in Novelis IPO, Bloomberg News reports	RE
May. 02	Aurobindo Pharma Completes Sale of US Arm's Business Assets	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

India's Hindalco mulls seeking $1.2 bln in Novelis IPO, Bloomberg News reports	May. 08	RE
Aurobindo Pharma Completes Sale of US Arm's Business Assets	May. 02	MT
Aurobindo Pharma Arms Commission Four New Plants in Andhra Pradesh, India	Apr. 02	MT
Aurobindo Pharma Gets US FDA Final Nod for Mometasone Furoate Monohydrate Nasal Spray	Mar. 19	MT
Aurobindo Pharma Limited Receives Final Approval from the US Food & Drug Administration	Mar. 19	CI
Aurobindo Pharma Limited Receives USFDA Approval for Fingolimod Capsules, 0.5 Mg	Mar. 01	CI
Indian shares set to rise on strong domestic growth, in-line US inflation data	Feb. 29	RE
US FDA Completes Inspection of Aurobindo Pharma's Injectibles Unit	Feb. 29	MT
Ex-dividend day for interim dividend	Feb. 19	FA
US FDA Clears Aurobindo Pharma Arm's Manufacturing Unit in Telangana, India	Feb. 16	MT
Aurobindo Pharma Limited Receives USFDA Approval for Deflazacort Tablets, 6 mg, 18 mg, 30 mg, and 36 mg	Feb. 12	CI
Aurobindo Pharma Clocks Gains in Fiscal Q3 Consolidated Net Profit	Feb. 12	MT
Aurobindo Pharma Limited Approves Second Interim Dividend, Payable on or Before March 4, 2024	Feb. 10	CI
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO	Jan. 23	RE
Aurobindo Pharma's Telangana Facility Receives 'Voluntary Action Indicated' Classification from US FDA	Jan. 09	MT
Aurobindo Pharma Gets Final US FDA Nod for Darunavir Tablets	Nov. 29	MT
Aurobindo Pharma Receives USFDA Approval for Darunavir Tablets, 600 mg and 800 mg	Nov. 29	CI
Aurobindo Pharma Sets Up Trading Unit	Nov. 22	MT
Aurobindo Pharma Limited Announces Incorporation of Wholly Owned Subsidiary as Auro Trading Private Limited	Nov. 22	CI
Ex-dividend day for interim dividend	Nov. 19	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Aurobindo Pharma

Equities

AUROPHARMA

INE406A01037

Highlights

Filters